QUINCE

Welcome to the Brand page for “QUINCE”, which is offered here for Pharmaceutical, medicinal and biological preparations for the treatment and prevention of alzheimer's, brain disorders, neurological disorders, arthritis, infectious disease, genetic disease, autoimmune disease, inflammatory disease, diabetes, cardiovascular disease, cancer, periodontal disease, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders;medical and scientific study and research; pharmaceutical research and development; pharmaceutical and biological research, testing, and product development consultation; conducting clinical trials for others in the fields of alzheimer's, brain disorders, neurological disorders, arthritis, infectious disease, genetic disease, autoimmune disease, inflammatory disease, diabetes, cardiovascular disease, cancer, periodontal disease, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders;.

Its status is currently believed to be active. Its class is unavailable. “QUINCE” is believed to be currently owned by “QUINCE THERAPEUTICS, INC.”